Nature Biotechnology asks selected members of the international community to comment on the ethical issues raised by the prospect of CRISPR-Cas9 engineering of the human germline.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Synthetic chimeric nucleases function for efficient genome editing
Nature Communications Open Access 04 December 2019
-
One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
European Journal of Human Genetics Open Access 30 November 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Supplementary information
Supplementary Text and Figures
Supplementary Comments (PDF 454 kb)
Rights and permissions
About this article
Cite this article
Bosley, K., Botchan, M., Bredenoord, A. et al. CRISPR germline engineering—the community speaks. Nat Biotechnol 33, 478–486 (2015). https://doi.org/10.1038/nbt.3227
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3227
This article is cited by
-
The Ethics of Gene Editing from an Islamic Perspective: A Focus on the Recent Gene Editing of the Chinese Twins
Science and Engineering Ethics (2020)
-
Synthetic chimeric nucleases function for efficient genome editing
Nature Communications (2019)
-
One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
European Journal of Human Genetics (2018)
-
The evolution of CRISPR/Cas9 and their cousins: hope or hype?
Biotechnology Letters (2018)